Title: "Assessing Risk of Incident Cognitive Impairment Using Stages of Objective Memory Impairment (SOMI) and CSF biomarkers"
Authors: Kellen K. Petersen PhD, Ellen Grober PhD, Richard B. Lipton MD, Bhargav Nallapu PhD, and Ali Ezzati MD
Disclaimer: Neurodiction LLC, has no relationship with this work. The post is for informational purposes only.
Title: Comparison of Plasma-based Biomarkers and Cognitive Assessments in predicting progression of MCI to Dementia Authors: Bhargav T. Nallapu, PhD, Kellen K. Petersen, PhD, Richard B. Lipton, MD, Da
Title: Stages of Objective Memory Impairment (SOMI) Predicts Incident Cognitive Impairment: Results from the Knight ADRC Authors: Ellen Grober PhD, Kellen K. Petersen PhD, Ali Ezzati MD, Jason Hassen
Title: Targeting the Correct Population for Trials: A Post-hoc Analysis of Trial of Solanezumab for Mild Dementia Due to Alzheimer’s disease. Authors: Ali Ezzati, MD; Kellen K. Petersen, PhD, Bhargav